Jeremy H. Herskowitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeremy H. Herskowitz has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
Kelsey M. Greathouse
Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA
10 shared publications- Kelsey M. Greathouse
University of Alabama at Birmingham, Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL, 35294
6 shared publications - Nicholas T. Seyfried
Center for Neurodegenerative Diseases, Emory University, Atlanta, USA
6 shared publications Audrey J. Weber
Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA
5 shared publicationsBenjamin W. Henderson
University of Alabama at Birmingham
5 shared publicationsErik G. Gentry
Center for Neurodegeneration and Experimental Therapeutics and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States
5 shared publications
Latest Publications
- Open Access
Tau seeds induce neurofibrillary tangle formation across brain regions via individual-specific connectivity
- Open Access
- 1 April 2026
- Published by Society for Neuroscience in eneuro
- Vol. 13 (4)
A Multi-Network Approach Identifies Proteins Related to Dendritic Spines in Alzheimer’s Disease
Proteomic studies have generated robust assessments of protein abundance changes in Alzheimer's disease (AD); however, identifying how the protein abundance changes affect specific biological processes remains a challenge. To address these hurdles, we used a multi-network computational analysis approach that integrated dendritic spine morphometry data with mass spectrometry-based proteomics from the same individuals. The samples exhibited a range of AD neuropathology and were categorized into three groups: controls, asymptomatic AD, and AD cases. Multiplex tandem mass tag mass spectrometry proteomic data ( N = 8,212 proteins) was generated on Brodmann area 46 (BA46) dorsolateral prefrontal cortex (DLPFC) human samples ( N = 41, 23 males and 18 females), from which dendritic spine morphometry analysis existed. To integrate the multi-scale data types, two computational network analysis methods were performed, including weighted coexpression network analysis (WGCNA) and SpeakEasy2 (SE2). Both WGCNA and SE2 revealed that the mitochondria protein modules were decreased in AsymAD and AD cases compared with controls, whereas the DNA repair modules were increased in AsymAD and AD compared with controls. Synaptic protein modules that correlated to multiple spine morphology traits were identified in both WGCNA and SE2. Pearson’s correlation analyses identified over a dozen individual proteins linked to multiple dendritic spine density and morphology traits. Collectively, these findings demonstrate how integration of spine morphometry data with proteomics can contextualize proteins for functional validation and identify synaptic alterations in AD progression.
- 1 April 2026
- Published by Society for Neuroscience in eneuro
- Vol. 13 (4)
Open AccessA Multi-Network Approach Identifies Proteins Related to Dendritic Spines in Alzheimer’s Disease
Proteomic studies have generated robust assessments of protein abundance changes in Alzheimer's disease (AD); however, identifying how the protein abundance changes affect specific biological processes remains a challenge. To address these hurdles, we used a multi-network computational analysis approach that integrated dendritic spine morphometry data with mass spectrometry-based proteomics from the same individuals. The samples exhibited a range of AD neuropathology and were categorized into three groups: controls, asymptomatic AD, and AD cases. Multiplex tandem mass tag mass spectrometry proteomic data ( N = 8,212 proteins) was generated on Brodmann area 46 (BA46) dorsolateral prefrontal cortex (DLPFC) human samples ( N = 41, 23 males and 18 females), from which dendritic spine morphometry analysis existed. To integrate the multi-scale data types, two computational network analysis methods were performed, including weighted coexpression network analysis (WGCNA) and SpeakEasy2 (SE2). Both WGCNA and SE2 revealed that the mitochondria protein modules were decreased in AsymAD and AD cases compared with controls, whereas the DNA repair modules were increased in AsymAD and AD compared with controls. Synaptic protein modules that correlated to multiple spine morphology traits were identified in both WGCNA and SE2. Pearson’s correlation analyses identified over a dozen individual proteins linked to multiple dendritic spine density and morphology traits. Collectively, these findings demonstrate how integration of spine morphometry data with proteomics can contextualize proteins for functional validation and identify synaptic alterations in AD progression.
- Open Access
- 6 February 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (2) , e71149
NRN1 as a therapeutic target for Alzheimer's disease
INTRODUCTION: Neuritin‐1 (NRN1) was identified as a synaptic protein associated with cognitive resilience to Alzheimer's disease (AD). METHODS: Target risk score and cell type expression profiles were generated for NRN1 using methods developed by the Emory‐Sage‐SGC‐JAX Target Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT‐AD) Center and Seattle Alzheimer's Disease Brain Cell Atlas (SEA‐AD). Antibody characterization was conducted using Western blots and densitometry to assess the relative protein abundances of NRN1 in rodents, humans, and cell models. RESULTS: NRN1 has a TREAT‐AD target risk score of 3.29 out of 5. Based on single‐nucleus RNA sequencing from SEA‐AD, NRN1 expression in excitatory neurons tends to decrease with increasing donor pseudo‐progression. Abcam ab64186 polyclonal NRN1 antibody detects NRN1 protein in vitro and in vivo at molecular weights that suggest NRN1 forms a homodimer. NRN1 protein abundance is comparable among controls and primary tauopathy cases, as well as Tau P301S mice and non‐transgenic littermates at 3 and 9 months. DISCUSSION: These findings advance the investigation of NRN1 as a therapeutic candidate for AD.
- 6 February 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (2) , e71149
Open AccessNRN1 as a therapeutic target for Alzheimer's disease
INTRODUCTION: Neuritin‐1 (NRN1) was identified as a synaptic protein associated with cognitive resilience to Alzheimer's disease (AD). METHODS: Target risk score and cell type expression profiles were generated for NRN1 using methods developed by the Emory‐Sage‐SGC‐JAX Target Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT‐AD) Center and Seattle Alzheimer's Disease Brain Cell Atlas (SEA‐AD). Antibody characterization was conducted using Western blots and densitometry to assess the relative protein abundances of NRN1 in rodents, humans, and cell models. RESULTS: NRN1 has a TREAT‐AD target risk score of 3.29 out of 5. Based on single‐nucleus RNA sequencing from SEA‐AD, NRN1 expression in excitatory neurons tends to decrease with increasing donor pseudo‐progression. Abcam ab64186 polyclonal NRN1 antibody detects NRN1 protein in vitro and in vivo at molecular weights that suggest NRN1 forms a homodimer. NRN1 protein abundance is comparable among controls and primary tauopathy cases, as well as Tau P301S mice and non‐transgenic littermates at 3 and 9 months. DISCUSSION: These findings advance the investigation of NRN1 as a therapeutic candidate for AD.
- Open Access
- 31 October 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 27 (11) , 2240-2252
Integration across biophysical scales identifies molecular and cellular correlates of person-to-person variability in human brain connectivity
Brain connectivity arises from interactions across biophysical scales, ranging from molecular to cellular to anatomical to network level. To date, there has been little progress toward integrated analysis across these scales. To bridge this gap, from a unique cohort of 98 individuals, we collected antemortem neuroimaging and genetic data, as well as postmortem dendritic spine morphometric, proteomic and gene expression data from the superior frontal and inferior temporal gyri. Through the integration of the molecular and dendritic spine morphology data, we identified hundreds of proteins that explain interindividual differences in functional connectivity and structural covariation. These proteins are enriched for synaptic structures and functions, energy metabolism and RNA processing. By integrating data at the genetic, molecular, subcellular and tissue levels, we link specific biochemical changes at synapses to connectivity between brain regions. These results demonstrate the feasibility of integrating data from vastly different biophysical scales to provide a more comprehensive understanding of brain connectivity.
- 31 October 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 27 (11) , 2240-2252
Open AccessIntegration across biophysical scales identifies molecular and cellular correlates of person-to-person variability in human brain connectivity
Brain connectivity arises from interactions across biophysical scales, ranging from molecular to cellular to anatomical to network level. To date, there has been little progress toward integrated analysis across these scales. To bridge this gap, from a unique cohort of 98 individuals, we collected antemortem neuroimaging and genetic data, as well as postmortem dendritic spine morphometric, proteomic and gene expression data from the superior frontal and inferior temporal gyri. Through the integration of the molecular and dendritic spine morphology data, we identified hundreds of proteins that explain interindividual differences in functional connectivity and structural covariation. These proteins are enriched for synaptic structures and functions, energy metabolism and RNA processing. By integrating data at the genetic, molecular, subcellular and tissue levels, we link specific biochemical changes at synapses to connectivity between brain regions. These results demonstrate the feasibility of integrating data from vastly different biophysical scales to provide a more comprehensive understanding of brain connectivity.
- Open Access
Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathology
Alzheimer’s (AD) and Parkinson disease (PD) pathology often co-occur. Amyloid-β and phosphorylated tau are found in 30-50% of idiopathic PD cases, while α-synuclein inclusions are present in 50% of AD cases. These co-pathologies are linked to increased mortality and earlier onset of cognitive decline. Immune activation is a hallmark of these neurodegenerative diseases, but current models primarily examine each pathology in isolation. How these co-pathologies drive inflammation and neuronal loss remains poorly understood. We therefore developed a mouse model combining tau, amyloid-β, and α-synuclein. We found that co-pathologies synergistically trigger an amplified neuroimmune response, with expanded populations of CD4 + and CD8 + tissue-resident memory T cells and CD68 + microglia, compared to single pathologies. These changes were abundant in the hippocampus and cortex, regions with elevated protein pathology load and enhanced neuronal loss. Our findings demonstrate that co-pathologies enhance proteinopathy and synergistically enhance immune activation and neurodegeneration, suggesting that combinatorial therapeutic strategies that target both co-pathologies and inflammation, may be disease modifying. Summary: Webster et al. demonstrate that co-occurring Alzheimer’s and Parkinson disease protein pathologies, common in cognitively impaired patient populations, amplify proteinopathy and synergistically enhance CNS neuroinflammatory responses and neurodegeneration. This work supports the need for combinatorial therapeutic strategies and positions neuroinflammation as an important link for co-pathology enhanced neurodegeneration.
Open AccessTau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathology
Alzheimer’s (AD) and Parkinson disease (PD) pathology often co-occur. Amyloid-β and phosphorylated tau are found in 30-50% of idiopathic PD cases, while α-synuclein inclusions are present in 50% of AD cases. These co-pathologies are linked to increased mortality and earlier onset of cognitive decline. Immune activation is a hallmark of these neurodegenerative diseases, but current models primarily examine each pathology in isolation. How these co-pathologies drive inflammation and neuronal loss remains poorly understood. We therefore developed a mouse model combining tau, amyloid-β, and α-synuclein. We found that co-pathologies synergistically trigger an amplified neuroimmune response, with expanded populations of CD4 + and CD8 + tissue-resident memory T cells and CD68 + microglia, compared to single pathologies. These changes were abundant in the hippocampus and cortex, regions with elevated protein pathology load and enhanced neuronal loss. Our findings demonstrate that co-pathologies enhance proteinopathy and synergistically enhance immune activation and neurodegeneration, suggesting that combinatorial therapeutic strategies that target both co-pathologies and inflammation, may be disease modifying. Summary: Webster et al. demonstrate that co-occurring Alzheimer’s and Parkinson disease protein pathologies, common in cognitively impaired patient populations, amplify proteinopathy and synergistically enhance CNS neuroinflammatory responses and neurodegeneration. This work supports the need for combinatorial therapeutic strategies and positions neuroinflammation as an important link for co-pathology enhanced neurodegeneration.
- Open Access
- 9 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (32) , eadn5181
Dendritic spine head diameter predicts episodic memory performance in older adults
Episodic memory in older adults is varied and perceived to rely on numbers of synapses or dendritic spines. We analyzed 2157 neurons among 128 older individuals from the Religious Orders Study and Rush Memory and Aging Project. Analysis of 55,521 individual dendritic spines by least absolute shrinkage and selection operator regression and nested model cross-validation revealed that the dendritic spine head diameter in the temporal cortex, but not the premotor cortex, improved the prediction of episodic memory performance in models containing β amyloid plaque scores, neurofibrillary tangle pathology, and sex. These findings support the emerging hypothesis that, in the temporal cortex, synapse strength is more critical than quantity for memory in old age.
- 9 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (32) , eadn5181
Open AccessDendritic spine head diameter predicts episodic memory performance in older adults
Episodic memory in older adults is varied and perceived to rely on numbers of synapses or dendritic spines. We analyzed 2157 neurons among 128 older individuals from the Religious Orders Study and Rush Memory and Aging Project. Analysis of 55,521 individual dendritic spines by least absolute shrinkage and selection operator regression and nested model cross-validation revealed that the dendritic spine head diameter in the temporal cortex, but not the premotor cortex, improved the prediction of episodic memory performance in models containing β amyloid plaque scores, neurofibrillary tangle pathology, and sex. These findings support the emerging hypothesis that, in the temporal cortex, synapse strength is more critical than quantity for memory in old age.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Investigating Dendritic Spine Morphology as a Mediator of Cognitive Outcomes in Aged Diversity Outbred Mice
Background: The intersection of genetic diversity, memory, and synaptic function is a critical component in better understanding age‐related cognitive decline. Diversity Outbred mice offer the opportunity to investigate cognitive aging across a genetically diverse population in a controlled lab environment. DO mice exhibit an appreciable amount of variance in Contextual Fear Memory and Acquisition (CFM, CFA), which can be linked to individual differences in genetic background (Ouellette A. et al, 2022, Cell Reports). Here, we investigate the role of dendritic spines as a mediator of individual age‐related changes in memory.Methods: 524 DO mice (289 female, 235 male) were aged to either 8 or 18‐months. All mice received contextual fear conditioning (CFC) at 8mo, while another suet received an additional recall test at 17mo and renewal at 18mo. After CFC a subset of brains from each cohort were collected for spine morphology analyses (females, n = 42). One CA1 pyramidal neuron from each brain was imaged and quantified for the density of thin, stubby, mushroom and/or filipodia classified spines in addition to spine volume.Results: While was not a decline in CFM or CFA between 8 and 18mo, we observed expectedly wide range in individual memory outcomes. Thin spine density significantly decreased between 8mo and 18mo, and stubby spine density increased. Spine volume across all spine types increased with age. Apical thin spine density explained 61% of the variance in CFM outcomes, while thin spine volume explained 79% and 43% of variance CFA in apical and basal dendrites respectively. Thin spine density, however, did not associate with CFA outcomes.Conclusions: We have linked dendritic spine density and morphology as a potential mediator of individual outcomes across a genetically diverse population. Our results suggest that there may be an age‐related conversion of thin to stubby spine types, and that mice with fewer thin spines are more likely to have better CFM outcomes, coinciding with reports of thin spines as dynamic “learning spines” rather than “memory storage” spines (Hayashi, Y. 2005, Neuron). We also show that the size of these “learning” thin spines may be more important memory acquisition than their total density.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessInvestigating Dendritic Spine Morphology as a Mediator of Cognitive Outcomes in Aged Diversity Outbred Mice
Background: The intersection of genetic diversity, memory, and synaptic function is a critical component in better understanding age‐related cognitive decline. Diversity Outbred mice offer the opportunity to investigate cognitive aging across a genetically diverse population in a controlled lab environment. DO mice exhibit an appreciable amount of variance in Contextual Fear Memory and Acquisition (CFM, CFA), which can be linked to individual differences in genetic background (Ouellette A. et al, 2022, Cell Reports). Here, we investigate the role of dendritic spines as a mediator of individual age‐related changes in memory.Methods: 524 DO mice (289 female, 235 male) were aged to either 8 or 18‐months. All mice received contextual fear conditioning (CFC) at 8mo, while another suet received an additional recall test at 17mo and renewal at 18mo. After CFC a subset of brains from each cohort were collected for spine morphology analyses (females, n = 42). One CA1 pyramidal neuron from each brain was imaged and quantified for the density of thin, stubby, mushroom and/or filipodia classified spines in addition to spine volume.Results: While was not a decline in CFM or CFA between 8 and 18mo, we observed expectedly wide range in individual memory outcomes. Thin spine density significantly decreased between 8mo and 18mo, and stubby spine density increased. Spine volume across all spine types increased with age. Apical thin spine density explained 61% of the variance in CFM outcomes, while thin spine volume explained 79% and 43% of variance CFA in apical and basal dendrites respectively. Thin spine density, however, did not associate with CFA outcomes.Conclusions: We have linked dendritic spine density and morphology as a potential mediator of individual outcomes across a genetically diverse population. Our results suggest that there may be an age‐related conversion of thin to stubby spine types, and that mice with fewer thin spines are more likely to have better CFM outcomes, coinciding with reports of thin spines as dynamic “learning spines” rather than “memory storage” spines (Hayashi, Y. 2005, Neuron). We also show that the size of these “learning” thin spines may be more important memory acquisition than their total density.
- Open Access
A Molecular Basis of Human Brain Connectivity
Neuroimaging is commonly used to infer human brain connectivity, but those measurements are far-removed from the molecular underpinnings at synapses. To uncover the molecular basis of human brain connectivity, we analyzed a unique cohort of 98 individuals who provided neuroimaging and genetic data contemporaneous with dendritic spine morphometric, proteomic, and gene expression data from the superior frontal and inferior temporal gyri. Through cellular contextualization of the molecular data with dendritic spine morphology, we identified hundreds of proteins related to synapses, energy metabolism, and RNA processing that explain between-individual differences in functional connectivity and structural covariation. By integrating data at the genetic, molecular, subcellular, and tissue levels, we bridged the divergent fields of molecular biology and neuroimaging to identify a molecular basis of brain connectivity. One-Sentence Summary Dendritic spine morphometry and synaptic proteins unite the divergent fields of molecular biology and neuroimaging.
Open AccessA Molecular Basis of Human Brain Connectivity
Neuroimaging is commonly used to infer human brain connectivity, but those measurements are far-removed from the molecular underpinnings at synapses. To uncover the molecular basis of human brain connectivity, we analyzed a unique cohort of 98 individuals who provided neuroimaging and genetic data contemporaneous with dendritic spine morphometric, proteomic, and gene expression data from the superior frontal and inferior temporal gyri. Through cellular contextualization of the molecular data with dendritic spine morphology, we identified hundreds of proteins related to synapses, energy metabolism, and RNA processing that explain between-individual differences in functional connectivity and structural covariation. By integrating data at the genetic, molecular, subcellular, and tissue levels, we bridged the divergent fields of molecular biology and neuroimaging to identify a molecular basis of brain connectivity. One-Sentence Summary Dendritic spine morphometry and synaptic proteins unite the divergent fields of molecular biology and neuroimaging.
- Open Access
- 13 April 2023
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 43 (20) , 3764-3785
Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length
Proteomic studies utilizing postmortem human brain tissue samples have yielded robust assessments of the aging and neurodegenerative disease(s) proteomes. While these analyses provide lists of molecular alterations in human conditions, like Alzheimer’s disease (AD), identifying individual proteins that affect biological processes remains a challenge. To complicate matters, protein targets may be highly understudied and have limited information on their function. To address these hurdles, we sought to establish a blueprint to aid selection and functional validation of targets from proteomic datasets. A cross-platform pipeline was engineered to focus on synaptic processes in the entorhinal cortex of human patients, including controls, preclinical AD, and AD cases. Label-free quantification mass spectrometry data (n=2,260 proteins) was generated on synaptosome fractionated tissue from Brodmann area 28 (n=58 samples). In parallel, dendritic spine density and morphology was measured in the same individuals. Weighted gene co-expression network analysis was used to construct a network of protein co-expression modules that were correlated with dendritic spine metrics. Module-trait correlations were used to guide unbiased selection of Twinfilin-2 (TWF2), which was the top hub protein of a module that positively correlated with thin spine length. Using CRISPR-dCas9 activation strategies, we demonstrated that boosting endogenous TWF2 protein levels in primary hippocampal neurons increased thin spine length, thus providing experimental validation for the human network analysis. Collectively, this study describes alterations in dendritic spine density and morphology as well as synaptic proteins and phosphorylated tau from the entorhinal cortex of preclinical and advanced stage AD patients.Significance Statement:Proteomic studies can yield vast lists of molecules that are altered under various experimental or disease conditions. Here, we provide a blueprint to facilitate mechanistic validation of protein targets from human brain proteomic datasets. We conducted a proteomic analysis of human entorhinal cortex samples spanning cognitively normal and Alzheimer's disease cases with a comparison of dendritic spine morphology in the same samples. Network integration of proteomics with dendritic spine measurements allowed for unbiased discovery of Twinfilin-2 as a regulator of dendritic spine length. A proof-of-concept experiment in cultured neurons demonstrated that altering Twinfilin-2 protein level induced corresponding changes in dendritic spine length, thus providing experimental validation for the computational framework.
- 13 April 2023
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 43 (20) , 3764-3785
Open AccessCross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length
Proteomic studies utilizing postmortem human brain tissue samples have yielded robust assessments of the aging and neurodegenerative disease(s) proteomes. While these analyses provide lists of molecular alterations in human conditions, like Alzheimer’s disease (AD), identifying individual proteins that affect biological processes remains a challenge. To complicate matters, protein targets may be highly understudied and have limited information on their function. To address these hurdles, we sought to establish a blueprint to aid selection and functional validation of targets from proteomic datasets. A cross-platform pipeline was engineered to focus on synaptic processes in the entorhinal cortex of human patients, including controls, preclinical AD, and AD cases. Label-free quantification mass spectrometry data (n=2,260 proteins) was generated on synaptosome fractionated tissue from Brodmann area 28 (n=58 samples). In parallel, dendritic spine density and morphology was measured in the same individuals. Weighted gene co-expression network analysis was used to construct a network of protein co-expression modules that were correlated with dendritic spine metrics. Module-trait correlations were used to guide unbiased selection of Twinfilin-2 (TWF2), which was the top hub protein of a module that positively correlated with thin spine length. Using CRISPR-dCas9 activation strategies, we demonstrated that boosting endogenous TWF2 protein levels in primary hippocampal neurons increased thin spine length, thus providing experimental validation for the human network analysis. Collectively, this study describes alterations in dendritic spine density and morphology as well as synaptic proteins and phosphorylated tau from the entorhinal cortex of preclinical and advanced stage AD patients.Significance Statement:Proteomic studies can yield vast lists of molecules that are altered under various experimental or disease conditions. Here, we provide a blueprint to facilitate mechanistic validation of protein targets from human brain proteomic datasets. We conducted a proteomic analysis of human entorhinal cortex samples spanning cognitively normal and Alzheimer's disease cases with a comparison of dendritic spine morphology in the same samples. Network integration of proteomics with dendritic spine measurements allowed for unbiased discovery of Twinfilin-2 as a regulator of dendritic spine length. A proof-of-concept experiment in cultured neurons demonstrated that altering Twinfilin-2 protein level induced corresponding changes in dendritic spine length, thus providing experimental validation for the computational framework.
- Open Access
- 5 April 2023
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 22 (5) , 100542
Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer’s Disease
- 5 April 2023
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 22 (5) , 100542
Open AccessIntegrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer’s Disease